세계의 장 중첩증 시장 보고서(2025년)

Intussusception is a medical condition wherein one part of the intestine slides into an adjacent section, causing a blockage in the flow of food, fluids, and gas through the affected portion. This condition manifests with symptoms such as severe abdominal pain, vomiting, and bloody stools. Diagnosis of intussusception typically relies on symptoms, physical examination, and imaging tests.

There are two main types of intussusception are idiopathic intussusception and secondary intussusception. Idiopathic intussusception involves the telescoping or invagination of one part of the intestine into another, resulting in a blockage or obstruction that can often be treated non-surgically through procedures such as pneumatic or hydrostatic reduction. Treatment methods include enema reduction, surgery, and others, with diagnostic approaches such as barium enema, ultrasound, and X-ray. These services are generally provided by hospitals, clinics, and other medical facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The intussusception market research report is one of a series of new reports from The Business Research Company that provides intussusception market statistics, including intussusception industry global market size, regional shares, competitors with an intussusception market share, detailed intussusception market segments, market trends and opportunities, and any further data you may need to thrive in the intussusception industry. This intussusception market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intussusception market size has grown steadily in recent years. It will grow from $4.45 billion in 2024 to $4.67 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to improved diagnostic capabilities, increased awareness and education, global healthcare infrastructure growth, research and development investments, collaboration among healthcare entities.

The intussusception market size is expected to see steady growth in the next few years. It will grow to $5.46 billion in 2029 at a compound annual growth rate (CAGR) of 4.0%. The growth in the forecast period can be attributed to continued medical education initiatives, pediatric vaccination programs, global efforts in pediatric healthcare, focus on postoperative care, rising demand for pediatric gastrointestinal research, telemedicine and remote healthcare access. Major trends in the forecast period include advancements in diagnostic imaging, minimally invasive treatment approaches, development of pediatric-specific interventions, research on etiology and risk factors, global epidemiological studies, implementation of vaccination programs, telemedicine for diagnosis and consultation.

The forecast of 4.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder pediatric care by inflating prices of air enema reduction systems and pediatric surgical supplies developed in the UK and Brazil, resulting in delayed treatment of bowel obstructions and higher pediatric emergency costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in the incidence of intestinal disorders is poised to drive the growth of the intussusception market in the future. Intestinal disorders encompass various medical conditions affecting the normal functioning of the intestines, which play a crucial role in the digestive system. The increasing occurrence of intestinal disorders, such as inflammatory bowel disease and gastrointestinal cancers, can lead to earlier diagnoses, improved treatment options, and enhanced support for patients with intussusception, ultimately contributing to better health outcomes. For instance, data from the American Cancer Society (ACS) in January 2023 revealed a 3.18% increase in gastrointestinal cancers in the United States, reaching 348,840 cases compared to 338,090 in 2021. Therefore, the rising incidence of intestinal disorders is expected to drive the growth of the intussusception market.

The growth of the intussusception market is being fueled by rising healthcare spending. This term encompasses the total financial resources allocated to the healthcare sector within a particular region, country, or organization. Increased healthcare spending is often driven by the need for medical interventions, diagnostic procedures, and potential surgical treatments associated with conditions like intussusception, which in turn affects overall healthcare expenditure. For example, in November 2023, the Canadian Institute for Health Information, a Canada-based organization, projected that total health spending in Canada would reach $344 billion in 2023, averaging $8,740 per person. This represents a 2.8% increase compared to the previous year, which experienced a mere 1.5% growth in health spending in 2022, indicating a significant recovery in healthcare investment. Thus, the rise in healthcare spending is contributing to the growth of the intussusception market.

Major companies in the intestinal pseudo-obstruction treatment market are actively involved in developing innovative drug therapies, such as NHE3 inhibitor treatment therapy, to provide reliable services to customers. NHE3 inhibitor treatment therapy involves the inhibition of the Sodium-Proton-Exchanger subtype 3 (NHE3) in the gut. For example, in April 2022, Ardelyx Inc., a US-based biopharmaceutical company, introduced IBSRELA, an NHE3 inhibitor treatment designed for irritable bowel syndrome with constipation (IBS-C) in adults. This therapy has the potential to improve gastrointestinal motility by inhibiting or blocking the activity of the Sodium-Hydrogen Exchanger 3 (NHE3) protein. The approval of IBSRELA was based on two Phase 3 trials involving over 1,200 IBS-C patients. The treatment significantly improved abdominal pain and bowel movements, meeting the primary endpoint. Notably, improvements were observed as early as Week 1 and sustained for 26 weeks in the long-term trial.

In March 2022, Pfizer Inc., a prominent US-based pharmaceutical manufacturing company, acquired Arena Pharmaceuticals, Inc. This acquisition is part of Pfizer's strategic efforts to bolster its portfolio of therapeutic candidates at various stages of development within the field of gastroenterology. Arena Pharmaceuticals, Inc., a US-based clinical-stage company, is actively involved in developing treatments for intestinal diseases, including intussusception (bowel obstruction). The acquisition aligns with Pfizer's commitment to advancing research and development in gastrointestinal therapeutics.

Major companies operating in the intussusception market report are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Abbott Laboratories, Sanofi S.A., GlaxoSmithKline PLC, Stryker Corporation, Boston Scientific Corporation, Biogen Inc., Olympus Corporation, GE HealthCare Technologies Inc., Steris PLC, Cook Medical LLC, Shimadzu Corporation, Carestream Health, CONMED Corporation, Janssen Pharmaceuticals Inc., EndoChoice Holdings Inc., Fujifilm Healthcare Solutions, Basilea Pharmaceutica Ltd., Richard Wolf GmbH, Karl Storz SE And Co. KG, Eizoflex Co. Ltd., Arena Pharmaceuticals Inc.

North America was the largest region in the intussusception market in 2024. The regions covered in the intussusception market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intussusception market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intussusception market consists of revenues earned by entities that provide diagnostic services such as clinical examination, magnetic resonance imaging, exploratory laparoscopy, or laparotomy that help in diagnosing and managing intussusception as a medical condition. The market value includes the value of related goods sold by the service provider or included within the service offering. The intussusception market also includes sales of drugs such as acetaminophen with codeine and ibuprofen. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intussusception Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intussusception market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intussusception ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intussusception market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Idiopathic Intussusception; Secondary Intussusception
• 2) By Treatment: Enema Reduction; Surgery; Other Treatment
• 3) By Diagnosis: Barium Enema; Ultrasound; X-Ray; Computerized Tomography (CT)
• 4) By End-User: Hospitals; Clinics; Other End-User
• Subsegments:
• 1) By Idiopathic Intussusception: Childhood Idiopathic Intussusception; Adult Idiopathic Intussusception
• 2) By Secondary Intussusception: Neoplastic Intussusception; Infectious Intussusception; Inflammatory Intussusception; Post-Surgical Intussusception
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc; Bayer AG; Novartis AG; Bristol-Myers Squibb Company; Abbott Laboratories; Sanofi S.A.; GlaxoSmithKline plc; Stryker Corporation; Boston Scientific Corporation; Biogen Inc.; Olympus Corporation; GE HealthCare Technologies Inc.; Steris Plc; Cook Medical LLC; Shimadzu Corporation; Carestream Health; CONMED Corporation; Janssen Pharmaceuticals Inc.; EndoChoice Holdings Inc.; Fujifilm Healthcare Solutions; Basilea Pharmaceutica Ltd.; Richard Wolf GmbH; Karl Storz SE And Co. KG; Eizoflex Co. Ltd.; Arena Pharmaceuticals Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intussusception Market Characteristics

3. Intussusception Market Trends And Strategies

4. Intussusception Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Intussusception Growth Analysis And Strategic Analysis Framework

• 5.1. Global Intussusception PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Intussusception Market Growth Rate Analysis
• 5.4. Global Intussusception Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Intussusception Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Intussusception Total Addressable Market (TAM)

6. Intussusception Market Segmentation

• 6.1. Global Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Idiopathic Intussusception
• Secondary Intussusception
• 6.2. Global Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enema Reduction
• Surgery
• Other Treatment
• 6.3. Global Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Barium Enema
• Ultrasound
• X-Ray
• Computerized Tomography (CT)
• 6.4. Global Intussusception Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Other End-User
• 6.5. Global Intussusception Market, Sub-Segmentation Of Idiopathic Intussusception, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Childhood Idiopathic Intussusception
• Adult Idiopathic Intussusception
• 6.6. Global Intussusception Market, Sub-Segmentation Of Secondary Intussusception, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neoplastic Intussusception
• Infectious Intussusception
• Inflammatory Intussusception
• Post-Surgical Intussusception

7. Intussusception Market Regional And Country Analysis

• 7.1. Global Intussusception Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Intussusception Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Intussusception Market

• 8.1. Asia-Pacific Intussusception Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Intussusception Market

• 9.1. China Intussusception Market Overview
• 9.2. China Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Intussusception Market

• 10.1. India Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Intussusception Market

• 11.1. Japan Intussusception Market Overview
• 11.2. Japan Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Intussusception Market

• 12.1. Australia Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Intussusception Market

• 13.1. Indonesia Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Intussusception Market

• 14.1. South Korea Intussusception Market Overview
• 14.2. South Korea Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Intussusception Market

• 15.1. Western Europe Intussusception Market Overview
• 15.2. Western Europe Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Intussusception Market

• 16.1. UK Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Intussusception Market

• 17.1. Germany Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Intussusception Market

• 18.1. France Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Intussusception Market

• 19.1. Italy Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Intussusception Market

• 20.1. Spain Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Intussusception Market

• 21.1. Eastern Europe Intussusception Market Overview
• 21.2. Eastern Europe Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Intussusception Market

• 22.1. Russia Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Intussusception Market

• 23.1. North America Intussusception Market Overview
• 23.2. North America Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Intussusception Market

• 24.1. USA Intussusception Market Overview
• 24.2. USA Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Intussusception Market

• 25.1. Canada Intussusception Market Overview
• 25.2. Canada Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Intussusception Market

• 26.1. South America Intussusception Market Overview
• 26.2. South America Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Intussusception Market

• 27.1. Brazil Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Intussusception Market

• 28.1. Middle East Intussusception Market Overview
• 28.2. Middle East Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Intussusception Market

• 29.1. Africa Intussusception Market Overview
• 29.2. Africa Intussusception Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Intussusception Market Competitive Landscape And Company Profiles

• 30.1. Intussusception Market Competitive Landscape
• 30.2. Intussusception Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Intussusception Market Other Major And Innovative Companies

• 31.1. Abbott Laboratories
• 31.2. Sanofi S.A.
• 31.3. GlaxoSmithKline plc
• 31.4. Stryker Corporation
• 31.5. Boston Scientific Corporation
• 31.6. Biogen Inc.
• 31.7. Olympus Corporation
• 31.8. GE HealthCare Technologies Inc.
• 31.9. Steris Plc
• 31.10. Cook Medical LLC
• 31.11. Shimadzu Corporation
• 31.12. Carestream Health
• 31.13. CONMED Corporation
• 31.14. Janssen Pharmaceuticals Inc.
• 31.15. EndoChoice Holdings Inc.

32. Global Intussusception Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intussusception Market

34. Recent Developments In The Intussusception Market

35. Intussusception Market High Potential Countries, Segments and Strategies

• 35.1 Intussusception Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Intussusception Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Intussusception Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer